Miroprofen

Miroprofen
Clinical data
Other namesAntopen; BRN 0888858; NSC 261037; Ro 07-0582; Y 9213; 2-[4-(1,7-diazabicyclo[4.3.0]nona-2,4,6,8-tetraen-8-yl)phenyl]propanoic acid
ATC code
  • none
Identifiers
  • (RS)-2-(4-imidazo[1,2-a]pyridin-2-ylphenyl)propanoic acid
CAS Number
PubChem CID
ChemSpider
UNII
ChEBI
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC16H14N2O2
Molar mass266.300 g·mol−1
3D model (JSmol)
ChiralityRacemic mixture
  • O=C(O)C(c3ccc(c1nc2ccccn2c1)cc3)C
  • InChI=1S/C16H14N2O2/c1-11(16(19)20)12-5-7-13(8-6-12)14-10-18-9-3-2-4-15(18)17-14/h2-11H,1H3,(H,19,20) checkY
  • Key:OJGQFYYLKNCIJD-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Miroprofen (INN) is an analgesic and NSAID, meaning that it has anti-inflammatory, antipyretic and antiplatelet aggregation activity. Chemically it is a carboxylic acid belonging to the group of phenylpropanoic acids.[1]

References

  1. ^ Mikashima H, Goto K (January 1982). "[Inhibitory effect of 2-(4-(2-imidazo(1,2-a)pyridyl)phenyl) propionic acid (miroprofen) on platelet aggregation and prostaglandin I2 generation (author's transl)]". Yakugaku Zasshi. 102 (1): 99–103. doi:10.1248/yakushi1947.102.1_99. PMID 7045328.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.